Cargando…
Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma
Pancreatic adenocarcinoma is one of the most lethal diseases with a 5-year survival rate of about 8%. ASXL2 is an epigenetic regulator associated with various tumors including colorectal cancer, breast cancer, and myeloid leukemia. However, the role of ASXL2 in pancreatic cancer remains unclear. Thi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531590/ https://www.ncbi.nlm.nih.gov/pubmed/34692512 http://dx.doi.org/10.3389/fonc.2021.736694 |